KCG
TPST icon

Knight Capital Group’s Tempest Therapeutics TPST Stock Holding History

Knight Capital Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$525K Buy
+13
New +$489K 0.01% 1663

Other funds holding TPST

DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BBT Capital Management Fort Worth, Texas $85.5M AUM 11.09% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Knight Capital Group's TPST Position: Q2 2013 in Review

Knight Capital Group opened a new position in Tempest Therapeutics (TPST) in Q2 2013: 13 shares worth $525K. The stake represents 0.01% of the portfolio and ranks #1663 among its holdings.

29 funds tracked by Wall St. Rank hold TPST as of Q2 2013.

  • Knight Capital Group held 13 shares of Tempest Therapeutics worth $525K as of Q2 2013.
  • Tempest Therapeutics was a new Knight Capital Group position in Q2 2013.
  • Tempest Therapeutics made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #1663 holding.
  • 29 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.